Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.1B | 6.1B | 5.7B | 6.2B |
| Cost of revenue | 3.9B | 3.6B | 3.4B | 3.5B |
| Gross profit | 3.2B | 2.4B | 2.3B | 2.8B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.2B | 1.3B | 1.1B | 1.1B |
| Operating income | 2.0B | 1.1B | 1.1B | 1.6B |
| Non operating interest income | ||||
| Income | 19M | 22M | 12M | 12M |
| Expense | 245M | 231M | 154M | 156M |
| Other income expense | 48M | 76M | 69M | 67M |
| Pretax income | 1.8B | 1.0B | 1.0B | 1.6B |
| Tax provision | 415M | 208M | 283M | 425M |
| Net income | 1.4B | 801M | 752M | 1.1B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 2.3B | 1.4B | 1.4B | 1.9B |
| Net income from continuing op. | 1.4B | 801M | 752M | 1.1B |
| Minority interests | -31M | -13M | -5M | -15M |
| Preferred stock dividends | — | — | — | — |